Founder Naman Gosalia champions prevention‑first heart care, bringing India‑born AnginaX to global forums like the World Heart Federation.
AnginaX combines advanced science, precise preventive pathways, and intelligent systems to shift from reactive treatment to continuous lifelong cardiovascular health.
With cardiovascular disease causing nearly 18 million deaths annually, Gosalia urges early protection before symptoms, targeting clinicians, policymakers, and public‑health stakeholders worldwide.